Cutaneous ulceration induced by interferon alfa [3]

Annals of Pharmacotherapy

Volumn 38, Issue 1, 2004, Pages 173-174

  Gallelli, Luca ^a   Guadagnino, Vincenzo ^a   Caroleo, Benedetto ^a   Marigliano, Norma ^a   De Sarro, Giovambattista ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; PEGINTERFERON;

ADULT; ANTIBODY TITER; CASE REPORT; CELL INFILTRATION; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; IATROGENIC DISEASE; LETTER; LYMPHOID CELL; MALE; PRIORITY JOURNAL; REMISSION; SKIN ULCER; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345731429     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D198     Document Type: Letter

References (5)

1. Christian MM, Diven DG, Sanchez RL, Soloway RD. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. J Am Acad Dermatol 1997;37:118-20.
2. Kurzen H, Petzoldt D, Hartschuh W, Jappe U. Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha. Acta Derm Venereol 2002;82:310-2.
3. Pouthier D, Theissen F, Humbel RL. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient. Nephrol Dial Transplant 2002;17:174.
4. Bessis D, Charron A, Rouzier-Panis R, Blatiere V, Guilhou JJ, Reynes J. Necrotizing cutaneous lesions complicating treatment with pegylated-interferon alfa in an HIV-infected patient. Eur J Dermatol 2002;12:99-102.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.